Industry Connect with Novartis

Novartis Institutes for BioMedical Research (NIBR) have invited The University of Queensland, as one of a selected group of international institutions, to participate in their NIBR Global Scholars Program 2020.

The NIBR Global Scholars Program will provide UQ researchers with access to disease area drug-hunting and translational research expertise.

Selected proposals, not funded by traditional grant support, will receive up to US $1million over three years, inclusive of UQ overheads. Each funded proposal will have a dedicated NIBR science sponsor and alliance manager to work with the funded researcher/s and UniQuest.

NIBR and UniQuest invite you to submit a non-confidential 2 page pre-proposal.

Disease areas

Autoimmunity, Transplantation & Inflammation
Cardiovascular and Metabolic
Immuno-Oncology
Musculoskeletal Diseases
Neurosciences
Oncology
Ophthalmology
Respiratory Diseases
Tropical Diseases
Additional Disease Areas

Platform technologies

Analytical Sciences & Imaging
Biologics
Cell and Gene Therapy
Chemical and Biological Therapies
Discovery Chemistry
Engineering Technologies and Innovation

Next steps

Download disease/indications detailed in the NIBR Scientific Needs List

Email novartis@uniquest.com.au to request an application form

Non confidential pre-proposals must not exceed two pages

NIBR Global Scholars Program

Request for Applications open 1 July 2020

To check the disease/indications that NIBR are interested in, download the details in the NIBR Scientific Needs List.
Interested researchers should reach out to their UniQuest representative or email novartis@uniquest.com.au to request the two-page non-confidential application form.

Applications close 24 July 2020

Forward completed applications to novartis@uniquest.com.au by 24 July 2020.

Contact us

Contact us for more information about this and other Industry Connect events.

Contact us